Cellyan Biotechnology Co., Ltd
HKPD· Nasdaq
HKPDCellyan Biotechnology Co., Ltd
Who holds Cellyan Biotechnology Co., Ltd, from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| StoneX Group Inc. | 102.3K | +159.7% | $52.4K | 0.1% | Aug 12, 2026 |
| Jane Street Group, LLC | 49.1K | New | $18.7K | 0% | Aug 14, 2026 |
| XTX Topco Ltd | 38.9K | New | $14.8K | 0.1% | Aug 14, 2026 |
| Clear Street Group Inc. | 12K | ±0% | $4.6K | 0% | Aug 12, 2026 |
| UBS Group AG | 1.1K | +882.7% | $411 | 0% | Aug 13, 2026 |
| HRT Financial LP | 41.8K | New | $15 | 0% | Aug 14, 2026 |
